Effective treatment with abciximab for consecutive bilateral middle cerebral artery occlusion

Cerebrovasc Dis. 2006;21(5-6):419-21. doi: 10.1159/000092131. Epub 2006 Mar 20.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / administration & dosage*
  • Drug Administration Schedule
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage*
  • Infarction, Middle Cerebral Artery / diagnostic imaging
  • Infarction, Middle Cerebral Artery / drug therapy*
  • Infusions, Intravenous
  • Middle Aged
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Radiography
  • Recurrence
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome
  • Ultrasonography

Substances

  • Antibodies, Monoclonal
  • Fibrinolytic Agents
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Tissue Plasminogen Activator
  • Abciximab